Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
LifeMD Inc has a consensus price target of $13 based on the ratings of 6 analysts. The high is $15 issued by Cantor Fitzgerald on August 20, 2024. The low is $10 issued by Keybanc on July 11, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Cantor Fitzgerald, and Keybanc on August 20, 2024, August 9, 2024, and July 11, 2024, respectively. With an average price target of $13.33 between Cantor Fitzgerald, Cantor Fitzgerald, and Keybanc, there's an implied 144.65% upside for LifeMD Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for LifeMD (NASDAQ:LFMD) was reported by Cantor Fitzgerald on August 20, 2024. The analyst firm set a price target for $15.00 expecting LFMD to rise to within 12 months (a possible 175.23% upside). 20 analyst firms have reported ratings in the last year.
The latest analyst rating for LifeMD (NASDAQ:LFMD) was provided by Cantor Fitzgerald, and LifeMD reiterated their overweight rating.
There is no last upgrade for LifeMD
There is no last downgrade for LifeMD.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeMD was filed on August 20, 2024 so you should expect the next rating to be made available sometime around August 20, 2025.
While ratings are subjective and will change, the latest LifeMD (LFMD) rating was a reiterated with a price target of $15.00 to $15.00. The current price LifeMD (LFMD) is trading at is $5.45, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.